Metabolic engineering of Streptomyces explomaris for increased production of the reverse antibiotic nybomycin.
Saved in:
| Title: | Metabolic engineering of Streptomyces explomaris for increased production of the reverse antibiotic nybomycin. |
|---|---|
| Authors: | Shu W; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany., Stegmüller J; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany., Rodriguez-Estevez M; Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany., Rückert-Reed C; CEBITEC, Bielefeld University, Bielefeld, Germany., Kalinowski J; CEBITEC, Bielefeld University, Bielefeld, Germany., Gromyko O; Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, Ukraine.; Microbial Culture Collection of Antibiotic Producers, Ivan Franko National University of Lviv, Lviv, Ukraine., Rebets Y; Explogen LLC, Lviv, Ukraine., Luzhetskyy A; Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany., Wittmann C; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany. christoph.wittmann@uni-saarland.de. |
| Source: | Microbial cell factories [Microb Cell Fact] 2025 Oct 30; Vol. 24 (1), pp. 227. Date of Electronic Publication: 2025 Oct 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2859 (Electronic) Linking ISSN: 14752859 NLM ISO Abbreviation: Microb Cell Fact Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
